The largest database of trusted experimental protocols

6 protocols using epignome kit

1

Whole-Genome Bisulfite Sequencing of Sorted Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from the sorted cells by using a DNA-extraction kit (QIAGEN) and then bisulfite treated using an EZ DNA methylation kit (Zymo Research). The bisulfite-modified DNA-sequencing library was generated using the EpiGnome™ kit (Epicenter) per the manufacturer’s instructions. WGBS was performed as described previously. Briefly, bisulfite-modified DNA sequencing libraries were generated using the EpiGenome kit (Epicenter) according to the manufacturer’s instructions. Bisulfite-modified DNA libraries were sequenced using Illumina HiSeq 4000 and NovaSeq 6000 systems (Abdelsamed et al., 2017 (link)). Sequencing data were aligned to the HG19 genome using the BSMAP v. 2.74 software (Xi and Li, 2009 (link)). Differential analysis of CpG methylation among the datasets was determined with a Bayesian hierarchical model to detect regional methylation differences with at least three CpG sites (Wu et al., 2015 (link)). Data are shown from only samples that yielded enough genomic material (~or > 2,000 cells) for genome-wide sequencing coverage and other quality control parameters. Notably, bisulfite modification for the patient 15 week 2 sample had low conversion (deamination of unmethylated cytosines) and was therefore excluded from methylation analyses.
+ Open protocol
+ Expand
2

Epigenetic Profiling of Plaque Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from 5mg of plaque tissue, using the MasterPure™ DNA Purification Kit (Epicentre) according to the manufacturer’s instructions. Bisulfite treatment of genomic DNA was then performed using the Zymo EZ DNA Methylation Lightning Kit. The bisulfite-treated DNA was purified on a spin column and used to prepare the sequencing library using the EpiGnome™ Kit (Epicentre). Paired-end sequencing with 150-bp read lengths was performed on Illumina HiSeq X10 instrument. Methylation analysis was performed using Bismark (v0.17.0). In summary, FASTQ files were quality-filtered and adapter sequences trimmed using Trimmomatic. A bisulfite-converted UCSC hg19 reference genome file was generated using Bowtie, and the EpiGnome library sequence data were aligned to the reference genome. Methylation information was extracted for those DGEs identified from the RNA-seq analyses. The promoter region was defined as 1500bp before and 500bp after the TSS of each gene. Fisher test was used to identify statistic significant changes on the methylation ratios.
+ Open protocol
+ Expand
3

Genome-Wide DNA Methylation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from the control and the DAC-treated CT26 cells and PDX tumors using a QIAamp genomic DNA Kit (Qiagen, Stockach, Germany) according to the instructions. Bisulfite treatment of genomic DNA was performed using a DNA Methylation Lightning Kit (Zymo EZ, CA, USA). Briefly, 200–500 ng of purified genomic DNA was treated with the Zymo Lightning Conversion Reagent in a thermal cycler for 8 min at 98 °C, followed by 60 min at 54 °C. The bisulfite-treated DNA was purified on a spin column and used to prepare the sequencing library using an EpiGnome Kit (Epicentre, Wisconsin, USA). In this procedure, bisulfite-treated single-stranded DNA was random-primed using a polymerase able to read uracil nucleotides to synthesize DNA that contained a specific sequence tag. The 3′ ends of the newly synthesized DNA strands were then selectively tagged with a second specific sequence, which resulted in doubly tagged DNA molecules with known sequence tags at their 5′ and 3′ ends. The EpiGnome libraries were diluted and loaded onto the cBot DNA Cluster Generation System. After the cluster generation was completed, the flow cell was transferred to the HiSeq 3000 System for sequencing using 75 bp paired-end reads. Additional sequencing could be completed for higher coverage when necessary. The data were analyzed according to the GO database and KEGG database.
+ Open protocol
+ Expand
4

Whole-Genome Bisulfite Sequencing of Sorted Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from the sorted cells by using a DNA-extraction kit (QIAGEN) and then bisulfite treated using an EZ DNA methylation kit (Zymo Research). The bisulfite-modified DNA-sequencing library was generated using the EpiGnome™ kit (Epicenter) per the manufacturer’s instructions. WGBS was performed as described previously. Briefly, bisulfite-modified DNA sequencing libraries were generated using the EpiGenome kit (Epicenter) according to the manufacturer’s instructions. Bisulfite-modified DNA libraries were sequenced using Illumina HiSeq 4000 and NovaSeq 6000 systems (Abdelsamed et al., 2017 (link)). Sequencing data were aligned to the HG19 genome using the BSMAP v. 2.74 software (Xi and Li, 2009 (link)). Differential analysis of CpG methylation among the datasets was determined with a Bayesian hierarchical model to detect regional methylation differences with at least three CpG sites (Wu et al., 2015 (link)). Data are shown from only samples that yielded enough genomic material (~or > 2,000 cells) for genome-wide sequencing coverage and other quality control parameters. Notably, bisulfite modification for the patient 15 week 2 sample had low conversion (deamination of unmethylated cytosines) and was therefore excluded from methylation analyses.
+ Open protocol
+ Expand
5

Whole Genome Bisulfite Sequencing and T Cell Multipotency

Check if the same lab product or an alternative is used in the 5 most similar protocols
WGBS was performed as previously described14 (link),32 (link). Briefly, genomic DNA was bisulfite-treated using the EZ DNA Methylation gold kit (Zymo Research). Subsequently, the bisulfite-modified DNA underwent sequencing library generation using the EpiGnome kit (Epicentre) as per manufacturer’s instructions. Bisulfite-modified DNA libraries were sequenced using an Illumina HiSeq system. Sequencing data were aligned to the HG19 genome using BSMAP v.2.74 software53 (link). Differential methylation analysis of CpG methylation among the datasets was determined with a Bayesian hierarchical model to detect regional methylation differences with at least three CpG sites54 (link).
The T cell multipotency index was used as previously described32 (link). Briefly, a supervised analysis of the methylomes from naive and HIV-specific CD8+ T cells identified 245 hypomethylated CpG sites, which were then used as input to a one-class logistic regression to calculate the multipotency index. The multipotency signature was applied to the sample WGBS datasets in which scores were calculated as the dot product between the DNA methylation value and the signature. The score was converted into the (0, 1) range in which multipotency values closer to 1 demonstrate a more naive-like cell.
+ Open protocol
+ Expand
6

Quantifying CEACAM5 Promoter Methylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The promoter methylation status of CEACAM5 was determined by NGS on bisulfite‐treated genomic DNA. Extracted DNA (100 ng) from the cell lines and clinical tissues was used for bisulfite treatment and methylation evaluation. A Zymo EZ DNA methylation Lightning Kit (Zymo Research) was used for bisulfite conversion, followed by an EpiGnome™ Kit (Epicenter) to prepare the bisulfite sequencing libraries before sequencing. Sequencing was performed with an Illumina HiSeq2500 genome sequencer (USA) to determine the reads of thymine and cytosine in each CpG site in the sequence. The proportion of reads between thymine and cytosine in the CpG sites can show the percentage of methylation of CpG sites. The methylation of CpG sites in the region from 1 to −1800 bp relative to the transcription start site of the CEACAM5 promoter sequence was analyzed.
HCT116 DKO non‐methylated DNA and human HCT116 DKO methylated DNA in the Human Methylated and Non‐methylated DNA Set (Zymo Research) were respectively used as the positive and negative controls in the methylation survey. The methylation level was calculated from reads between the selected CEACAM5 promoter sequence on each CpG site with reads of thymine and cytosine.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!